The stock looks cheap, but appearances can be deceiving.

Recursion Pharmaceuticals (RXRX) closed the last trading session at $8.59, gaining 20% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

That brings us to Recursion Pharmaceuticals (RXRX 3.04%), a biotech company specializing in drug discovery using artificial intelligence (AI). At least one notable name in the investing world thinks ...